Laminate Medical Technologies today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) granted their ...

In preparation for a planned commercial rollout, Telix has contracted with Cardinal Health to enable Zircaix® 2 availability across a wide range of U.S. locations. Kevin Richardson, Chief Executive ...

Laminate Medical Technologies announced that the United States Centers for Medicare & Medicaid Services (CMS) granted the ...

A noninvasive ultrasound technology called Break Wave™ lithotripsy (BWL) offers a safe and effective new option for treatment ...

A new device could keep organs viable for more than 24 hours - far longer than the current window of four to six hours ...

Dr David N. Cade, Chief Medical Officer at Telix said, “The results of the ZIRCON trial make a compelling case for TLX250-CDx as a breakthrough product for kidney cancer imaging, and validate CAIX as ...

The Hemopurifier® has received FDA Breakthrough Device designation for treating ... to demonstrate the Hemopurifier®'s benefits in kidney transplants. This report is based on a press release ...

Just click button below and allow notifications for this site Note Safari 16.4+ working on iOS devices also need this site app to ... thousands of K2 veterans have reported cancers, kidney problems ...

In 2022, the BWL system received Breakthrough Device Designation from the US Food ... across North America with stones located in the kidney (57% of patients) or ureter (43%).

Proteomics International Laboratories has hired industry veteran Dr James Williams to help guide it towards commercialising ...